Commodore Capital LP
- SEC CIK
- 0001831942
No open-market purchases or sales filed in the past year.
Current role at each company
- VERA Vera Therapeutics, Inc.10% Owneras of Jan 12, 2024
- VTGN Vistagen Therapeutics, Inc.10% Owneras of Oct 6, 2023
- ELVN Enliven Therapeutics, Inc.10% Owneras of Feb 27, 2023
- STSA Satsuma Pharmaceuticals, Inc.10% Owneras of Nov 16, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Commodore Capital LP as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
STSA Satsuma Pharmaceuticals, Inc.
10% Owner
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 16, 2022 (view filing) | Nov 14 | 2 days | Commodore Capital LP10% Owner | SSaleCommon Stock, par value $0.0001 per share | −3.25M | $0.71 | −$2.31M | −87.6%461.3K after | |
| Nov 29, 2021 (view filing) | Nov 24 | 5 days | Commodore Capital LP10% Owner | PPurchaseCommon Stock, par value $0.0001 per share | +2.92K | $5.42 | +$15.8K | +0.1%3.71M after | |
| Nov 23, 2021 (view filing) | Nov 19-22 | 4 days | Commodore Capital LP10% Owner | PPurchaseCommon Stock, par value $0.0001 per share | +13.2K | $5.48 | +$72.3K | +0.4%3.71M after | 2 lots |
| Nov 12, 2021 (view filing) | Nov 10-11 | 2 days | Commodore Capital LP10% Owner | PPurchaseCommon Stock, par value $0.0001 per share | +17.6K | $5.94 | +$104.3K | +0.5%3.70M after | 2 lots |
| Nov 10, 2021 (view filing) | Nov 8 | 2 days | Commodore Capital LP10% Owner | PPurchaseCommon Stock, par value $0.0001 per share | +560 | $5.99 | +$3.35K | 0.0%3.68M after | |
| Nov 8, 2021 (view filing) | Nov 4-5 | 4 days | Commodore Capital LP10% Owner | PPurchaseCommon Stock, par value $0.0001 per share | +9.20K | $5.94 | +$54.6K | +0.3%3.68M after | 2 lots |
| Nov 4, 2021 (view filing) | Nov 2 | 2 days | Commodore Capital LP10% Owner | PPurchaseCommon Stock, par value $0.0001 per share | +8.88K | $5.64 | +$50.1K | +0.2%3.67M after | |
| Nov 2, 2021 (view filing) | Oct 29 | 4 days | Commodore Capital LP10% Owner | PPurchaseCommon Stock, par value $0.0001 per share | +44.7K | $5.71 | +$255.0K | +1.2%3.66M after | |
| Oct 29, 2021 (view filing) | Oct 27-28 | 2 days | Commodore Capital LP10% Owner | PPurchaseCommon Stock, par value $0.0001 per share | +54.7K | $5.48 | +$299.4K | +1.5%3.61M after | 2 lots |
| Oct 25, 2021 (view filing) | Oct 21-22 | 4 days | Commodore Capital LP10% Owner | PPurchaseCommon Stock, par value $0.0001 per share | +60.4K | $5.45 | +$329.4K | +1.7%3.56M after | 2 lots |
| Oct 21, 2021 (view filing) | Oct 19-20 | 2 days | Commodore Capital LP10% Owner | PPurchaseCommon Stock, par value $0.0001 per share | +128.2K | $5.19 | +$665.2K | +3.8%3.50M after | 2 lots |
| Oct 19, 2021 (view filing) | Oct 15-18 | 4 days | Commodore Capital LP10% Owner | PPurchaseCommon Stock, par value $0.0001 per share | +162.2K | $4.84 | +$784.8K | +5.1%3.37M after | 2 lots |